Anixa Biosciences (ANIX) Tax Provisions (2011)

Anixa Biosciences' (ANIX) quarterly Tax Provisions came in at -$2.9 million in Q4 2011, down 584.17% on a QoQ basis from $600000.0 in Q3 2011.

Anixa Biosciences (ANIX) Tax Provisions (2011) Analysis & Trends

Anixa Biosciences (ANIX) has 1 years of Tax Provisions data on file, last reported at -$2.9 million in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Anixa Biosciences	123.62 Mn	123.62 Mn	-	-

Download Data

Date	Value
Oct 31, 2011	-2.91 Mn
Jul 31, 2011	600,000.00